SBRA
Sabra Healthcare REIT Inc
19.80$
+0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 19.5% | 16.1% | 8.1% | 11.7% | 4.4% | 4.3% | 5.5% | 10.9% | 3.5% | 3.4% | 3.7% | 3.4% | |
| 3.0% | 0.3% | 1.1% | 7.4% | 0.8% | 0.6% | 1.0% | 1.9% | 0.9% | 0.8% | 1.1% | 1.3% | |
| 3.0% | 0.3% | 1.1% | 7.4% | 0.8% | 0.6% | 1.0% | 1.9% | 0.9% | 0.8% | 1.1% | 1.3% | |
| 11.4% | 10.9% | 6.6% | 3.3% | 3.6% | 3.5% | 4.4% | 9.0% | 2.6% | 2.5% | 2.5% | 2.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 1.0% | 1.2% | 2.0% | 7.2% | 0.9% | – | – | |
| 79.7% | 82.0% | 88.7% | 85.2% | 87.8% | 88.0% | 88.3% | 86.5% | 86.3% | – | – | – | |
| 0.0% | 0.0% | 0.0% | 2.4% | 2.0% | 1.7% | 1.4% | – | – | – | – | – | |
| 1.0% | 1.1% | 1.2% | 2.4% | 2.0% | 1.7% | 1.4% | 0.9% | 0.7% | 0.6% | 0.5% | 1.2% | |
| 54.4% | 57.6% | 55.2% | 51.1% | 51.2% | 42.5% | 43.0% | 43.4% | 46.8% | 48.0% | 48.3% | 48.6% | |
| 1.5% | 1.4% | 1.7% | 1.5% | 1.4% | 1.8% | 2.4% | 2.4% | 5.9% | 4.3% | 4.2% | 6.1% | |
| 33.9% | 28.1% | 0.2% | 20.0% | 0.1% | 0.1% | 21.8% | 29.9% | 3.4% | 1.8% | 2.0% | 4.0% | |
| 1.5% | 1.4% | 1.7% | 1.5% | 1.4% | 1.2% | 2.4% | 2.4% | 2.5% | 1.4% | 1.3% | – | |
| 6.0% | 7.2% | 7.1% | 3.6% | 1.7% | 1.9% | 39.6% | 40.1% | 40.2% | 43.1% | 43.6% | 42.1% | |
| 45.6% | 42.4% | 44.8% | 48.8% | 48.8% | 57.5% | 57.0% | 56.6% | 53.2% | 52.0% | 51.7% | 51.4% | |
| -5.4% | -5.7% | -8.5% | -3.1% | -4.1% | -9.4% | -12.0% | -18.4% | -25.3% | -31.9% | -35.3% | -36.7% | |
| 2.3% | 2.5% | 2.9% | 1.5% | 2.7% | 3.1% | 3.5% | 3.7% | 4.0% | 4.3% | 4.5% | 4.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.